Dr. Vaibhav Sahai, MBBS, MS
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Pancreatic Cancer
Studies Skin Cancer
16 reported clinical trials
28 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Skin Cancer
Stage IV
Stage III
RAF positive
Affiliated Hospitals
Clinical Trials Vaibhav Sahai, MBBS, MS is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Pembrolizumab + Olaparib
for Pancreatic Cancer
This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. These proteins help repair damaged deoxyribonucleic acid (DNA) and, therefore, play a role in ensuring the stability of each cell's genetic material. When either of these genes is mutated, or altered, such that its protein product is not made or does not function correctly, DNA damage may not be repaired properly. As a result, cells are more likely to develop additional genetic alterations that can lead to some types of cancer, including pancreatic cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Olaparib is an inhibitor of PARP, a protein that helps repair damaged DNA. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of pembrolizumab to the usual treatment of olaparib may help to shrink tumors in patients with metastatic pancreatic cancer with BRCA1 or BRCA2 mutations.
Recruiting1 award Phase 237 criteria
More about Vaibhav Sahai, MBBS, MS
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Vaibhav Sahai, MBBS, MS has experience with
- Cisplatin
- Nivolumab
- Gemcitabine
- Capecitabine
- Carboplatin
- Etoposide
Breakdown of trials Vaibhav Sahai, MBBS, MS has run
Pancreatic Cancer
Skin Cancer
Cancer
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vaibhav Sahai, MBBS, MS specialize in?
Vaibhav Sahai, MBBS, MS focuses on Pancreatic Cancer and Skin Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vaibhav Sahai, MBBS, MS currently recruiting for clinical trials?
Yes, Vaibhav Sahai, MBBS, MS is currently recruiting for 10 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Vaibhav Sahai, MBBS, MS has studied deeply?
Yes, Vaibhav Sahai, MBBS, MS has studied treatments such as Cisplatin, Nivolumab, Gemcitabine.
What is the best way to schedule an appointment with Vaibhav Sahai, MBBS, MS?
Apply for one of the trials that Vaibhav Sahai, MBBS, MS is conducting.
What is the office address of Vaibhav Sahai, MBBS, MS?
The office of Vaibhav Sahai, MBBS, MS is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.